Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Doctors often have to give patients more than one drug to manage blood sugar and weight separately
Wegovy is the first and only weight-management medicine that is also FDA-approved to lower the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and either obesity or overweight
Brand-name tirzepatide (Mounjaro/Zepbound) costs $1,069 monthly
His approach is simple: treat the whole person, not just the symptom
The abdominal area provides the best absorption for both compounds
Semaglutide may be a suitable option for individuals who have struggled to achieve weight loss through diet and exercise alone and have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity, such as hypertension or type 2 diabetes
